These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36241128)

  • 1. Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention.
    Holch P; Absolom KL; Henry AM; Walker K; Gibson A; Hudson E; Rogers Z; Holmes M; Peacock R; Pini S; Gilbert A; Davidson S; Routledge J; Murphy A; Franks K; Hulme C; Hewison J; Morris C; McParland L; Brown J; Velikova G
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):664-676. PubMed ID: 36241128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.
    Holch P; Pini S; Henry AM; Davidson S; Routledge J; Brown J; Absolom K; Gilbert A; Franks K; Hulme C; Morris C; Velikova G;
    Pilot Feasibility Stud; 2018; 4():110. PubMed ID: 29992040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
    Absolom K; Warrington L; Hudson E; Hewison J; Morris C; Holch P; Carter R; Gibson A; Holmes M; Clayton B; Rogers Z; McParland L; Conner M; Glidewell L; Woroncow B; Dawkins B; Dickinson S; Hulme C; Brown J; Velikova G
    J Clin Oncol; 2021 Mar; 39(7):734-747. PubMed ID: 33417506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment.
    Absolom K; Holch P; Warrington L; Samy F; Hulme C; Hewison J; Morris C; Bamforth L; Conner M; Brown J; Velikova G;
    BMC Cancer; 2017 May; 17(1):318. PubMed ID: 28482877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
    Richards HS; Blazeby JM; Portal A; Harding R; Reed T; Lander T; Chalmers KA; Carter R; Singhal R; Absolom K; Velikova G; Avery KNL
    BMC Cancer; 2020 Jun; 20(1):543. PubMed ID: 32522163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting.
    Warrington L; Absolom K; Holch P; Gibson A; Clayton B; Velikova G
    BMJ Open; 2019 Feb; 9(1):e025185. PubMed ID: 30782751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).
    Absolom K; Gibson A; Velikova G
    Med Care; 2019 May; 57 Suppl 5 Suppl 1():S59-S65. PubMed ID: 30985598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy.
    Dawkins B; Absolom K; Hewison J; Warrington L; Hudson E; Holch P; Carter R; Gibson A; Holmes M; Rogers Z; Dickinson S; Morris C; Woroncow B; Brown J; Hulme C; Velikova G
    JCO Oncol Pract; 2024 Apr; 20(4):581-590. PubMed ID: 38266205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.
    Holch P; Warrington L; Bamforth LCA; Keding A; Ziegler LE; Absolom K; Hector C; Harley C; Johnson O; Hall G; Morris C; Velikova G
    Ann Oncol; 2017 Sep; 28(9):2305-2311. PubMed ID: 28911065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
    Tombal B; Saad F; Penson D; Hussain M; Sternberg CN; Morlock R; Ramaswamy K; Ivanescu C; Attard G
    Lancet Oncol; 2019 Apr; 20(4):556-569. PubMed ID: 30770294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy - A prospective pilot study.
    Møller PK; Pappot H; Bernchou U; Schytte T; Mortensen ZV; Brúnni MFÁ; Dieperink KB
    Tech Innov Patient Support Radiat Oncol; 2022 Mar; 21():8-15. PubMed ID: 34977367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative behavioural intervention to reduce drinking before elective orthopaedic surgery: the PRE-OP BIRDS feasibility RCT.
    Snowden C; Lynch E; Avery L; Haighton C; Howel D; Mamasoula V; Gilvarry E; McColl E; Prentis J; Gerrand C; Steel A; Goudie N; Howe N; Kaner E
    Health Technol Assess; 2020 Mar; 24(12):1-176. PubMed ID: 32131964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.
    Tran C; Dicker A; Leiby B; Gressen E; Williams N; Jim H
    J Med Internet Res; 2020 Mar; 22(3):e12689. PubMed ID: 32209536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.
    Bates A; Rushbrook S; Shapiro E; Grocott M; Cusack R
    Trials; 2020 Nov; 21(1):929. PubMed ID: 33203440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery.
    Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM
    BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.